Chen et al. recently demonstrated that the disruption of a collagen deposition program activated by IL-17 signaling, which drives immune exclusion, increases anti–PD-L1–mediated tumor regression in a murine model of cutaneous squamous cell carcinoma [125]. The gene discussed is CD274; the disease is neoplasm.